Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01045_DB01142_nanopub.RAAKgQO2uiYU7udNRMiYqsEOjCyNdLFhK2TA0Cis7OcZY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01045_DB01142 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01045_DB01142 label "DDI between Rifampicin and Doxepin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if rifampin is initiated, discontinued or dose changed. [drugbank_resource:DB01045_DB01142]" assertion.
- drugbank_resource:DB01045_DB01142 identifier "drugbank_resource:DB01045_DB01142" assertion.
- drugbank_resource:DB01045_DB01142 title "DDI between Rifampicin and Doxepin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if rifampin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01045 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01045_DB01142 assertion.
- drugbank:DB01142 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01045_DB01142 assertion.